
The current ATXI market cap is 1.19M. The company's latest EPS is USD -3.6600 and P/E is -0.10.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.71M | -2.82M | -3.16M | -1.6M | -1.91M |
Net Income | -4.34M | -2.73M | -3.04M | -1.54M | -1.85M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.21M | -3.74M | -8.04M | -14.54M | -11.28M |
Net Income | -5.15M | -3.73M | -3.55M | -10.38M | -11.65M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.31M | 4.99M | 2.63M | 2.67M | 3.59M |
Total Liabilities | 1.41M | 1.16M | 973k | 816k | 1.26M |
Total Equity | 1.9M | 3.83M | 1.65M | 1.86M | 2.33M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.25M | 3.96M | 6.85M | 1.85M | 2.67M |
Total Liabilities | 886k | 509k | 3.58M | 1.2M | 816k |
Total Equity | 2.36M | 3.45M | 3.27M | 654k | 1.86M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.12M | -5.37M | -8.26M | -9.03M | -1.19M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 4.53M | 8.51M | 9.08M | 9.84M | 2.09M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -4.61M | -3.75M | -7.6M | -9.45M | -9.03M |
Investing | -1M | N/A | N/A | -3M | N/A |
Financing | N/A | 4.38M | 10.54M | 7.53M | 9.84M |
Market Cap | 1.19M |
Price to Earnings Ratio | -0.10 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.45 |
Price to Book Ratio | 0.63 |
Dividend Yield | - |
Shares Outstanding | 3.18M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -89.04% |
52 Week High | 3.9313 |
52 Week Low | 0.3521 |
Spread (Intraday) | 0.2 (40%) |
Company Name | Avenue Therapeutics Inc |
Address |
3500 s dupont hwy dover, delaware 19901 |
Website | https://www.avenuetx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.